| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1129 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 970 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 931 | 2020 |
| Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses R Bos, L Rutten, JEM van der Lubbe, MJG Bakkers, G Hardenberg, ... npj Vaccines 5 (1), 91, 2020 | 347 | 2020 |
| A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism A Krarup, D Truan, P Furmanova-Hollenstein, L Bogaert, P Bouchier, ... Nature communications 6 (1), 8143, 2015 | 328 | 2015 |
| Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) DH Barouch, FL Tomaka, F Wegmann, DJ Stieh, G Alter, ML Robb, ... The Lancet 392 (10143), 232-243, 2018 | 324 | 2018 |
| Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters LH Tostanoski, F Wegmann, AJ Martinot, C Loos, K McMahan, ... Nature medicine 26 (11), 1694-1700, 2020 | 303 | 2020 |
| Molecular cloning and expression of human UDP-D-xylose: proteoglycan core protein β-D-xylosyltransferase and its first isoform XT-II C Götting, J Kuhn, R Zahn, T Brinkmann, K Kleesiek Journal of molecular biology 304 (4), 517-528, 2000 | 303 | 2000 |
| The genome of the vervet (Chlorocebus aethiops sabaeus) WC Warren, AJ Jasinska, R García-Pérez, H Svardal, C Tomlinson, ... Genome research 25 (12), 1921-1933, 2015 | 116 | 2015 |
| A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in … B Callendret, J Vellinga, K Wunderlich, A Rodriguez, R Steigerwald, ... PloS one 13 (2), e0192312, 2018 | 90 | 2018 |
| A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus RC Zahn, I Schelp, O Utermöhlen, D von Laer Journal of virology 81 (2), 457-464, 2007 | 86 | 2007 |
| Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species R Zahn, G Gillisen, A Roos, M Koning, E van der Helm, D Spek, ... PloS one 7 (12), e44115, 2012 | 72 | 2012 |
| A double-blind, randomized, placebo-controlled phase 1 study of Ad26. ZIKV. 001, an Ad26-vectored anti–Zika virus vaccine NC Salisch, KE Stephenson, K Williams, F Cox, L van der Fits, ... Annals of internal medicine 174 (5), 585-594, 2021 | 60 | 2021 |
| Immunogenicity and efficacy of one and two doses of Ad26. COV2. S COVID vaccine in adult and aged NHP L Solforosi, H Kuipers, M Jongeneelen, SK Rosendahl Huber, ... Journal of Experimental Medicine 218 (7), 2021 | 59 | 2021 |
| Ad26. COV2. S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease JEM van Der Lubbe, SK Rosendahl Huber, A Vijayan, L Dekking, ... npj Vaccines 6 (1), 39, 2021 | 59 | 2021 |
| Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides RC Zahn, FG Hermann, EY Kim, MD Rett, SM Wolinsky, RP Johnson, ... Gene therapy 15 (17), 1210-1222, 2008 | 59 | 2008 |
| Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection … MN Widjojoatmodjo, L Bogaert, B Meek, R Zahn, J Vellinga, J Custers, ... Vaccine 33 (41), 5406-5414, 2015 | 58 | 2015 |
| Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys JE Schmitz, RC Zahn, CR Brown, MD Rett, M Li, H Tang, S Pryputniewicz, ... PLoS pathogens 5 (12), e1000691, 2009 | 55 | 2009 |
| Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate R Roozendaal, J Hendriks, T van Effelterre, B Spiessens, L Dekking, ... npj Vaccines 5 (1), 112, 2020 | 54 | 2020 |
| Low-dose Ad26. COV2. S protection against SARS-CoV-2 challenge in rhesus macaques X He, A Chandrashekar, R Zahn, F Wegmann, J Yu, NB Mercado, ... Cell 184 (13), 3467-3473. e11, 2021 | 53 | 2021 |
